Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Adding the Team into T1 Translational Research: A Case Study of Multidisciplinary Team Science in the Evaluation of Biomarkers of Prostate Cancer Risk and Prognosis.

Marrone MT, Joshu CE, Peskoe SB, De Marzo AM, Heaphy CM, Lupold SE, Meeker AK, Platz EA.

Clin Chem. 2018 Dec 5. pii: clinchem.2018.293365. doi: 10.1373/clinchem.2018.293365. [Epub ahead of print]

PMID:
30518666
2.

There is no impact of exposure measurement error on latency estimation in linear models.

Peskoe SB, Spiegelman D, Wang M.

Stat Med. 2018 Dec 4. doi: 10.1002/sim.8038. [Epub ahead of print]

PMID:
30515870
3.

Identifying Predictors of Time to Soft-Tissue Reconstruction following Open Tibia Fractures.

Shammas RL, Mundy LR, Truong T, Weber JM, Grier AJ, Cho EH, Peskoe SB, Gage MJ, Hollenbeck ST.

Plast Reconstr Surg. 2018 Dec;142(6):1620-1628. doi: 10.1097/PRS.0000000000005007.

PMID:
30239497
4.

The effect of risk factor misclassification on the partial population attributable risk.

Wong BHW, Peskoe SB, Spiegelman D.

Stat Med. 2018 Apr 15;37(8):1259-1275. doi: 10.1002/sim.7559. Epub 2018 Jan 15.

5.

Current or recent smoking is associated with more variable telomere length in prostate stromal cells and prostate cancer cells.

Joshu CE, Peskoe SB, Heaphy CM, Kenfield SA, Mucci LA, Giovannucci EL, Stampfer MJ, Yoon G, Lee TK, Hicks JL, De Marzo AM, Meeker AK, Platz EA.

Prostate. 2018 Feb;78(3):233-238. doi: 10.1002/pros.23462. Epub 2017 Nov 22.

PMID:
29164645
6.

Racial/Ethnic Differences in the Associations of Overall and Central Body Fatness with Circulating Hormones and Metabolic Factors in US Men.

Lopez DS, Rohrmann S, Peskoe SB, Joshu CE, Tsilidis KK, Selvin E, Dobs AS, Kanarek N, Canfield S, Nelson WG, Platz EA.

Int J Endocrinol Metab. 2017 Apr 22;15(2):e44926. doi: 10.5812/ijem.44926. eCollection 2017 Apr.

7.

Differential long-term stability of microRNAs and RNU6B snRNA in 12-20 year old archived formalin-fixed paraffin-embedded specimens.

Peskoe SB, Barber JR, Zheng Q, Meeker AK, De Marzo AM, Platz EA, Lupold SE.

BMC Cancer. 2017 Jan 6;17(1):32. doi: 10.1186/s12885-016-3008-4.

8.

In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in situ hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading.

Picanço-Albuquerque CG, Morais CL, Carvalho FL, Peskoe SB, Hicks JL, Ludkovski O, Vidotto T, Fedor H, Humphreys E, Han M, Platz EA, De Marzo AM, Berman DM, Lotan TL, Squire JA.

Virchows Arch. 2016 May;468(5):607-17. doi: 10.1007/s00428-016-1904-2. Epub 2016 Feb 9.

PMID:
26861919
9.

Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial.

Murtola TJ, Gurel B, Umbehr M, Lucia MS, Thompson IM Jr, Goodman PJ, Kristal AR, Parnes HL, Lippman SM, Sutcliffe S, Peskoe SB, Barber JR, Drake CG, Nelson WG, De Marzo AM, Platz EA.

Cancer Epidemiol Biomarkers Prev. 2016 Mar;25(3):463-9. doi: 10.1158/1055-9965.EPI-15-0987. Epub 2015 Dec 29.

10.

A group randomized controlled trial integrating obesity prevention and control for postpartum adolescents in a home visiting program.

Haire-Joshu DL, Schwarz CD, Peskoe SB, Budd EL, Brownson RC, Joshu CE.

Int J Behav Nutr Phys Act. 2015 Jun 26;12:88. doi: 10.1186/s12966-015-0247-8.

11.

Prediagnostic Obesity and Physical Inactivity Are Associated with Shorter Telomere Length in Prostate Stromal Cells.

Joshu CE, Peskoe SB, Heaphy CM, Kenfield SA, Van Blarigan EL, Mucci LA, Giovannucci EL, Stampfer MJ, Yoon G, Lee TK, Hicks JL, De Marzo AM, Meeker AK, Platz EA.

Cancer Prev Res (Phila). 2015 Aug;8(8):737-42. doi: 10.1158/1940-6207.CAPR-15-0097. Epub 2015 May 19.

12.

Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancer.

Umbehr MH, Gurel B, Murtola TJ, Sutcliffe S, Peskoe SB, Tangen CM, Goodman PJ, Thompson IM, Lippman SM, Lucia MS, Parnes HL, Drake CG, Nelson WG, De Marzo AM, Platz EA.

Prostate Cancer Prostatic Dis. 2015 Sep;18(3):264-9. doi: 10.1038/pcan.2015.19. Epub 2015 May 5.

13.

Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer.

Peskoe SB, Joshu CE, Rohrmann S, McGlynn KA, Nyante SJ, Bradwin G, Dobs AS, Kanarek N, Nelson WG, Platz EA.

Prostate. 2015 Aug 1;75(11):1167-76. doi: 10.1002/pros.22998. Epub 2015 Apr 28.

14.

Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial.

Heaphy CM, Gaonkar G, Peskoe SB, Joshu CE, De Marzo AM, Lucia MS, Goodman PJ, Lippman SM, Thompson IM Jr, Platz EA, Meeker AK.

Prostate. 2015 Aug 1;75(11):1160-6. doi: 10.1002/pros.22997. Epub 2015 Apr 20.

15.

Do environmental factors modify the genetic risk of prostate cancer?

Loeb S, Peskoe SB, Joshu CE, Huang WY, Hayes RB, Carter HB, Isaacs WB, Platz EA.

Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):213-20. doi: 10.1158/1055-9965.EPI-14-0786-T. Epub 2014 Oct 23.

16.

Investigation of miR-21, miR-141, and miR-221 expression levels in prostate adenocarcinoma for associated risk of recurrence after radical prostatectomy.

Zheng Q, Peskoe SB, Ribas J, Rafiqi F, Kudrolli T, Meeker AK, De Marzo AM, Platz EA, Lupold SE.

Prostate. 2014 Dec;74(16):1655-62. doi: 10.1002/pros.22883. Epub 2014 Sep 22.

17.

Association of variants in genes related to the immune response and obesity with BPH in CLUE II.

Lopez DS, Peskoe SB, Tsilidis KK, Hoffman-Bolton J, Helzlsouer KJ, Isaacs WB, Smith MW, Platz EA.

Prostate Cancer Prostatic Dis. 2014 Dec;17(4):353-8. doi: 10.1038/pcan.2014.36. Epub 2014 Sep 16.

18.

A peripheral circulating TH1 cytokine profile is inversely associated with prostate cancer risk in CLUE II.

Bhavsar NA, Bream JH, Meeker AK, Drake CG, Peskoe SB, Dabitao D, De Marzo AM, Isaacs WB, Platz EA.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2561-7. doi: 10.1158/1055-9965.EPI-14-0010. Epub 2014 Aug 22.

19.

PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy.

Lotan TL, Carvalho FL, Peskoe SB, Hicks JL, Good J, Fedor H, Humphreys E, Han M, Platz EA, Squire JA, De Marzo AM, Berman DM.

Mod Pathol. 2015 Jan;28(1):128-137. doi: 10.1038/modpathol.2014.85. Epub 2014 Jul 4.

20.

Overexpression of α (1,6) fucosyltransferase associated with aggressive prostate cancer.

Wang X, Chen J, Li QK, Peskoe SB, Zhang B, Choi C, Platz EA, Zhang H.

Glycobiology. 2014 Oct;24(10):935-44. doi: 10.1093/glycob/cwu051. Epub 2014 Jun 5.

21.

GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.

Maldonado L, Brait M, Loyo M, Sullenberger L, Wang K, Peskoe SB, Rosenbaum E, Howard R, Toubaji A, Albadine R, Netto GJ, Hoque MO, Platz EA, Sidransky D.

J Urol. 2014 Nov;192(5):1542-8. doi: 10.1016/j.juro.2014.04.082. Epub 2014 Apr 21.

22.

Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.

Gurel B, Lucia MS, Thompson IM Jr, Goodman PJ, Tangen CM, Kristal AR, Parnes HL, Hoque A, Lippman SM, Sutcliffe S, Peskoe SB, Drake CG, Nelson WG, De Marzo AM, Platz EA.

Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):847-56. doi: 10.1158/1055-9965.EPI-13-1126. Epub 2014 Apr 18.

23.

Association of C-peptide and leptin with prostate cancer incidence in the Health Professionals Follow-up Study.

Lai GY, Giovannucci EL, Pollak MN, Peskoe SB, Stampfer MJ, Willett WC, Platz EA.

Cancer Causes Control. 2014 May;25(5):625-32. doi: 10.1007/s10552-014-0369-3. Epub 2014 Mar 25.

24.

The association between circulating high-sensitivity C-reactive protein concentration and pathologic measures of colonic inflammation.

Joshu CE, Tsilidis KK, Peskoe SB, Giardiello FM, Dluzniewski PJ, Nelson WG, Iacobuzio-Donahue CA, Platz EA.

Cancer Causes Control. 2014 Apr;25(4):409-18. doi: 10.1007/s10552-014-0343-0. Epub 2014 Jan 17.

25.

Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death.

Heaphy CM, Yoon GS, Peskoe SB, Joshu CE, Lee TK, Giovannucci E, Mucci LA, Kenfield SA, Stampfer MJ, Hicks JL, De Marzo AM, Platz EA, Meeker AK.

Cancer Discov. 2013 Oct;3(10):1130-41. doi: 10.1158/2159-8290.CD-13-0135. Epub 2013 Jun 18.

26.

Serum prostate-specific antigen (PSA) concentration is positively associated with rate of disease reclassification on subsequent active surveillance prostate biopsy in men with low PSA density.

Umbehr MH, Platz EA, Peskoe SB, Bhavsar NA, Epstein JI, Landis P, Partin AW, Carter HB.

BJU Int. 2014 Apr;113(4):561-7. doi: 10.1111/bju.12131. Epub 2013 Jun 7.

27.

Racial/ethnic differences in serum sex steroid hormone concentrations in US adolescent males.

Lopez DS, Peskoe SB, Joshu CE, Dobs A, Feinleib M, Kanarek N, Nelson WG, Selvin E, Rohrmann S, Platz EA.

Cancer Causes Control. 2013 Apr;24(4):817-26. doi: 10.1007/s10552-013-0154-8. Epub 2013 Jan 25.

28.

Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome.

Hurley PJ, Marchionni L, Simons BW, Ross AE, Peskoe SB, Miller RM, Erho N, Vergara IA, Ghadessi M, Huang Z, Gurel B, Park BH, Davicioni E, Jenkins RB, Platz EA, Berman DM, Schaeffer EM.

Proc Natl Acad Sci U S A. 2012 Sep 11;109(37):14977-82. doi: 10.1073/pnas.1203525109. Epub 2012 Aug 27.

29.

Incidence and progression of lower urinary tract symptoms in a large prospective cohort of United States men.

Platz EA, Joshu CE, Mondul AM, Peskoe SB, Willett WC, Giovannucci E.

J Urol. 2012 Aug;188(2):496-501. doi: 10.1016/j.juro.2012.03.125. Epub 2012 Jun 15.

30.

Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer.

Chaux A, Peskoe SB, Gonzalez-Roibon N, Schultz L, Albadine R, Hicks J, De Marzo AM, Platz EA, Netto GJ.

Mod Pathol. 2012 Nov;25(11):1543-9. doi: 10.1038/modpathol.2012.104. Epub 2012 Jun 8.

Supplemental Content

Loading ...
Support Center